|
Volumn 10, Issue 3, 2000, Pages 291-295
|
Interleukin-2 plus chemotherapy for patients with metastatic melanoma
a a a a a |
Author keywords
Biochemotherapy; Immunotherapy; Interleukin 2; Melanoma
|
Indexed keywords
ANTIEMETIC AGENT;
BLEOMYCIN;
CISPLATIN;
LOMUSTINE;
LYMPHOKINE;
RECOMBINANT INTERLEUKIN 2;
ADULT;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DISEASE COURSE;
DOSE RESPONSE;
DRUG HYPERSENSITIVITY;
DRUG WITHDRAWAL;
FEMALE;
HUMAN;
INJECTION SITE;
MALE;
MELANOMA;
MUCOSA INFLAMMATION;
NAUSEA;
PRIORITY JOURNAL;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 0033769877
PISSN: 09608931
EISSN: None
Source Type: Journal
DOI: 10.1097/00008390-200010030-00012 Document Type: Article |
Times cited : (3)
|
References (21)
|